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a b s t r a c t
Infection of type II alveolar epithelial (ATII) cells by inﬂuenza A viruses (IAV) correlates with severe
respiratory disease in humans and mice. To understand pathogenic mechanisms during IAV infection of
ATII cells, murine ATII cells were cultured to maintain a differentiated phenotype, infected with IAV-PR8,
which causes severe lung pathology in mice, and proteomics analyses were performed using liquid
chromatography–mass spectrometry. PR8 infection increased levels of proteins involved in interferon
signaling, antigen presentation, and cytoskeleton regulation. Proteins involved in mitochondrial
membrane permeability, energy metabolism, and chromatin formation had reduced levels in PR8-
infected cells. Phenotypic markers of ATII cells in vivo were identiﬁed, conﬁrming the differentiation
status of the cultures. Surfactant protein B had decreased levels in PR8-infected cells, which was
conﬁrmed by immunoblotting and immunoﬂuorescence assays. Analysis of ATII cell protein proﬁles will
elucidate cellular processes in IAV pathogenesis, which may provide insight into potential therapies to
modulate disease severity.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Inﬂuenza A virus (IAV) is a common cause of human respiratory
tract infections with epidemics causing signiﬁcant morbidity and
mortality worldwide. While most infections are mild, spread of
IAV to the lungs can result in severe pneumonia during annual
epidemics or due to infection by highly pathogenic strains, such as
avian H5N1 or H7N9 viruses (Guarner and Falcon-Escobedo, 2009;
Mauad et al., 2010; Shieh et al., 2010; Uiprasertkul et al., 2007).
Like other viruses, IAV depends on the host cellular machinery for
replication, which is orchestrated by complex interactions bet-
ween host and viral proteins. Further, the host cell is able to mount
antiviral responses to counter-act the effects of the virus. An
understanding of the complex interactions between IAV and host
cells is important for the development of novel strategies to inhibit
the viral replication cycle or enhance effective host antiviral
responses.
The host factors that contribute to pathogenesis during IAV
infection are frequently cell type-speciﬁc. Epithelial cells of the
upper and lower respiratory tracts are the primary sites of virus
replication in IAV infections. However, infection of the lower
respiratory tract is the most severe as it may result in damage to
the alveolar epithelium, thus compromising gas exchange in the
lungs (Blazejewska et al., 2011; Guarner and Falcon-Escobedo,
2009; Shieh et al., 2010). The alveolar type II (ATII) epithelial cells
located in the lower respiratory tract are involved in regeneration
to repair injured alveolar epithelium and produce pulmonary
surfactant phospholipids and proteins, which are critical to pre-
vent alveolar collapse (Rooney et al., 1994). ATII cells are infected
by IAV in fatal human cases of avian H5N1 and 2009 pandemic
H1N1 virus infections (Mauad et al., 2010; Shieh et al., 2010;
Weinheimer et al., 2012). Inﬂuenza A/PR/8/34 H1N1 virus (PR8), a
mouse adapted inﬂuenza strain, provokes destruction of ATII cells
in the alveoli of mice (Loosli et al., 1975), making it a suitable
model to study IAV pathogenesis in the lung. Primary murine ATII
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
http://dx.doi.org/10.1016/j.virol.2015.03.045
0042-6822/& 2015 Elsevier Inc. All rights reserved.
n Correspondence to: 875 Perimeter Dr., MS 3051, Moscow, ID 83844-3051, USA.
Tel.: þ1 208 885 4940; fax: þ1 208 885 7905.
E-mail address: tmiura@uidaho.edu (T.A. Miura).
1 Current afﬁliation: Department of Biology and Biotechnological Sciences
Botswana International University of Science and Technology, Palapye, Botswana.
2 Current afﬁliation: Department of Medicine, University of Washington,
Seattle, WA, USA
3 Current afﬁliation: Unilever, Englewood Cliffs, NJ, USA.
Virology 483 (2015) 96–107
cells thus provide a powerful in vitro model to determine the
effects of viral infection on these specialized pulmonary cell types,
which corresponds to pathology in the mouse model. We have
shown that differentiated cultures of primary murine ATII cells are
susceptible to PR8 infection in vitro, resulting in secretion of
various pro- and anti-inﬂammatory cytokines and chemokines
(Kebaabetswe et al., 2013). This approach, however, did not offer a
comprehensive analysis of viral–host protein interactions that
could be important to pathogenesis during infection of ATII cells.
Hence, examining protein expression in IAV-infected ATII cells
could offer a global picture of how these cells interact with IAV at
the cellular level.
Proteomics studies of inﬂuenza virus infections in macaques
(Brown et al., 2010), mice (Kumar et al., 2014), continuous cell
lines (Coombs et al., 2010; Kummer et al., 2014; Vester et al.,
2009), and primary human cells (Kroeker et al., 2012; Lietzen et al.,
2011; Liu et al., 2012) have provided insight into how IAV strains
alter the host proteome at cellular and organismal levels. However,
host responses to IAV infection are also, in part, speciﬁc to the cell
type. Analysis of primary murine ATII cells allows us to character-
ize the host response to infection in cells that are relevant to
severe disease and correlate these ﬁndings to pathological ﬁndings
in the mouse model. In this study, our aim was to utilize the
in vitro model of highly differentiated ATII cells and examine
cellular protein proﬁles following infection with PR8. We used
liquid chromatography–mass spectrometry (LC–MS) and the accu-
rate mass and time (AMT) tag approach (Zimmer et al., 2006) to
quantitate cellular proteins in PR8-infected and mock-inoculated
ATII cells. The proteomics data were conﬁrmed for a select set of
proteins by immunoblotting and/or immunoﬂuorescence assay.
These data provide information on the differentiated phenotype of
primary murine ATII cells and the effects of PR8 infection on the
cellular proteome, which suggest potential mechanisms of patho-
genesis during IAV infection of this critical cell type.
Results and discussion
Infection of primary, differentiated ATII cells by PR8
Primary ATII cells were isolated from mice and cultured to
maintain an ATII phenotype in vitro, as previously described
(Kebaabetswe et al., 2013). ATII cultures were inoculated with
PR8 or mock-inoculated and infection was analyzed by immuno-
ﬂuorescence assay and immunoblotting 24 h later. Viral hemag-
glutinin (HA) was detected by immunoﬂuorescence in PR8-, but
not mock-inoculated ATII cells (Fig. 1A). Confocal image analysis
demonstrated that HA-speciﬁc ﬂuorescence was detected within
the cytoplasm of infected cells (Fig. 1B). Further, the different
forms of HA: the uncleaved precursor, HA0 and cleaved forms, HA1
and HA2 were detected by immunoblot analysis (Fig. 1C). The
presence of the cleaved HA protein in cell lysates suggests that
differentiated ATII cells are capable of post-translational proces-
sing of HA, which is required for viral infectivity and correlates
with virulence of IAV strains (Blazejewska et al., 2011; Steinhauer,
1999). These data are in agreement with our previous study that
demonstrated productive infection of murine ATII cells by PR8
(Kebaabetswe et al., 2013). Infection of primary murine ATII cells
provides a robust system for analysis of PR8-regulated changes to
the cellular proteome in physiologically relevant target cells.
Protein proﬁles were analyzed 24 h after inoculation with PR8
because this allowed time for the virus to spread through-out the
culture without inducing overt cytopathic effects (Fig. 1A). In a
previous study, PR8 replication in primary murine ATII cells
peaked at 24 h (Kebaabetswe et al., 2013). This time point is
consistent with other proteomic studies using the same strain of
inﬂuenza A virus in different cell types, including primary cultures
(Coombs et al., 2010; Kroeker et al., 2012; Liu et al., 2012).
Inﬂuenza viral proteins identiﬁed by proteomics analyses
Four biological replicates each of mock-inoculated and PR8-
infected ATII cultures were analyzed by LC–MS-based proteomics
using the AMT tag approach. Five IAV proteins were detected
(Table 1): HA, neuraminidase (NA), nucleoprotein (NP), matrix 1
(M1), and non-structural protein 1 (NS1). These viral proteins were
present in all four replicates of the PR8-infected ATII cells. Peptides
mapping to NP and HA were also detected in two or fewer of the
mock samples. Kummer et al. (2014) demonstrated that these ﬁve
proteins are the most abundant viral proteins in PR8-infected MDCK
cells. HA, NA, NP, and M1 are present in infectious virions and are
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Fig. 1. Inﬂuenza viral infection of ATII cells. Primary murine ATII cells were mock-
treated or inoculated with PR8 for 24 h. Immunoﬂuorescence assay of viral
hemagglutinin protein (red) and nuclei stained with DAPI (blue) was imaged using
(A) epiﬂuorescence microscopy at 40 and (B) confocal microscopy at 60 .
Orthogonal views along the indicated cross lines are shown to the right and below
the projected Z-stack. Scale bar indicates 10 μm. (C) Immunoblot analysis of viral
HA protein isoforms in whole cell lysates. β-actin was used as a loading control.
Molecular weights in kDa are provided to the left. The images shown are
representative of three replicate experiments.
Table 1
Inﬂuenza A virus proteins identiﬁed by proteomics analysis.
Uniprot
ID
Viral protein Number of peptides
identiﬁed
Fold
Changea
(P-value)
P03466 Nucleoprotein (NP) 61 18.2
(0.049)
P03452 Hemagglutinin (HA) 39 15.3
(0.075)
P03468 Neuraminidase (NA) 8 (0.001)b
P03485 Matrix protein 1 (M1) 8 (0.014)b
P03496 Non-structural protein 1
(NS1)
4 (0.001)b
a Fold change expressed as ratio of signal intensity in PR8-infected/mock,
P-value determined by Student's t-test.
b G-test when not detected in mock.
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produced in great abundance during viral assembly (Hutchinson
et al., 2014; Kummer et al., 2014). Therefore, detecting these proteins
late during the replication cycle (24 h post-infection) is not surprising
and suggests that inﬂuenza virus is actively replicating in these cells.
NS1 has multiple roles during IAV infection, including inhibition of
cellular gene expression and the type I interferon response, and is
also expressed at high levels in infected cells (Fernandez-Sesma et al.,
2006; Garcia-Sastre et al., 1998). Proteins that form the viral RNA-
dependent RNA polymerase complex, PB1, PB2, and PA, the nuclear
export protein, NEP, and M2 protein are expressed in relatively low
abundance in infected cells (Kummer et al., 2014) and were not
detected by our analysis. Overall, we detected a similar proﬁle of viral
proteins as others have reported in proteomics analyses of inﬂuenza
virus-infected cells and animals (Brown et al., 2010; Lietzen et al.,
2011; Liu et al., 2012).
PR8-induced changes to the cellular proteome
Proteomics analyses were used to compare the ATII protein
proﬁles in PR8-infected and mock-inoculated cells using four biolo-
gical replicates for each treatment. Comparative statistical analyses of
control and infected samples were performed using a two-sample t-
test to assess differences in protein average abundance, and a G-test
to assess associations among factors due to the presence or absence of
a protein. This analysis identiﬁed 151 differentially regulated proteins:
46 up-regulated and 105 down-regulated by PR8 infection (Fig. 2).
The complete data set of peptides, proteins, and statistical analyses
are provided as Supplemental dataset. Proteins that mapped to a
single peptide were excluded from further analyses. Proteins that
were up-regulated by PR8 infection are associated with host defense,
including interferon-induced cellular response, MHC class I antigen
processing and presentation, and pathogen detection, and cytoskele-
tal proteins (Tables 2 and 3). Proteins that were decreased by infection
included those involved in cellular metabolism, response to stress or
cell damage, and regulation of cell death (Table 4). The signiﬁcance of
these functional groups is discussed below.
Cellular proteins increased by PR8 infection
Virus-infected cells produce type I interferons (IFNs), pleiotro-
pic cytokines that contribute to both inhibition of viral replication
and activation of downstream immune responses. Many viruses
counter-act the type I IFN response to promote successful infec-
tion. This tug-of-war between type I IFN production and antagon-
ism is central to the outcome of infection in favor of either the host
or virus. To identify proteins that are induced by type I IFNs
in murine model systems, the Interferome database (http://
interferome.its.monash.edu.au/interferome/) was queried with
the subset of proteins whose levels were signiﬁcantly increased
by PR8 infection and mapped to two or more peptides (Rusinova
et al., 2013). This analysis identiﬁed several IFN-induced proteins
that were up-regulated by PR8 infection, including antiviral
effector proteins (BST-2, IFITM3), pathogen recognition receptors
(TLR3), and multiple IFN-induced components of the MHC class I
antigen processing and presentation pathway (Table 2) (Der et al.,
1998; Dolken et al., 2008). Our proteomics analysis did not include
secreted proteins; therefore, we did not directly identify type I
IFNs. IFNs stimulate cells bearing the IFN α/β receptor, which can
be the cells that produced the IFNs in addition to neighboring cells.
Primary cultures of murine ATII cells are not homogeneously
susceptible to PR8 infection, as can be seen by heterogeneous
staining of viral antigens in our cultures (Fig. 1A) (Kebaabetswe
et al., 2013). Therefore, it is possible that the IFN-stimulated
proteins we are detecting come from either infected or uninfected
cells within the culture. Furthermore, it is possible that the type I
IFN response is protecting some cells in the culture from infection.
Additional studies to determine the role of this response in
limiting infection of the alveolar epithelium are needed.
The NS1 protein of inﬂuenza virus is a potent interferon
antagonist that targets multiple steps, including upstream viral
detection and signaling, IFN production, and downstream inhibi-
tion of antiviral effector proteins. There are differences in the
effectiveness of IFN antagonism by different inﬂuenza virus strains
and among host cell types. The NS1 protein of PR8 suppresses
expression of type I IFNs and IFN-induced genes in infected human
dendritic cells and lung epithelial cells, and is required for
virulence in mice with functional IFN responses (Fernandez-
Sesma et al., 2006; Garcia-Sastre et al., 1998; Kochs et al., 2009).
However, PR8 NS1 has been found to inhibit the IFN response by
human dendritic cells by a lesser degree than human isolates of
IAV (Haye et al., 2009). Furthermore, the multiple functions of NS1
are regulated by post-translational modiﬁcation, including phos-
phorylation, SUMOylation, and ISGylation (Hsiang et al., 2012;
Santos et al., 2013; Zhao et al., 2010). It is unknown how these
modiﬁcations of NS1 might affect IFN antagonism by PR8 speciﬁ-
cally in ATII cells. Finally, in addition to NS1, the PB2 and PB1-F2
proteins of IAV have been demonstrated to inhibit RIG-I signaling,
which is critical for production of type I IFN in response to IAV
infection (Graef et al., 2010; Opitz et al., 2007; Varga et al., 2011).
Our results suggest that PR8 does not completely impair IFN
signaling in differentiated murine ATII cells. However, we cannot
rule out the possibility of IFN-independent expression of these
proteins, as some can also be induced by other signaling pathways
(Bego et al., 2012).
One of the proteins that was most highly increased by PR8
infection was IFN-induced, bone marrow stromal antigen 2 (BST-2/
tetherin/CD317; Table 3). BST-2 is a lipid raft-associated membrane
protein that inhibits the release of a diversity of enveloped viruses
during the budding process. Although IAV uses lipid rafts for
budding (Takeda et al., 2003), there have been contradictory
ﬁndings regarding the role of BST-2 in restricting the release of
IAV from infected cells. Multiple studies report that BST-2 inhibits
the release of inﬂuenza virus-like particles but not infectious
viruses (Bruce et al., 2012; Watanabe et al., 2011; Winkler et al.,
2012; Yondola et al., 2011). In contrast, other studies found that
BST-2 reduces the amount of wild-type viral particles released
from infected cells (Mangeat et al., 2012; Narkpuk et al., 2014).
Both of these studies used IAV generated through reverse genetics,
which may account for the contrasting ﬁndings with the studies
that saw no effect of BST-2 on release of infectious virus. In
addition to a direct role in viral inhibition, BST-2 also functions
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Fig. 2. Murine proteins with statistically signiﬁcant expression in mock vs. PR8-
infected ATII cells. Proteomics analysis was performed on four replicates each of
mock-treated and PR8-infected murine ATII cell cultures. Comparative statistical
analyses of mock with PR8-infected samples were performed using a 2-sample
t-test to assess differences in protein average abundance, and a G-test to assess
associations among factors due to the presence/absence of response.
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as a viral detection and signaling molecule, leading to activation of
NFκB (Galao et al., 2012). While our results demonstrate that BST-
2 is part of the host cellular response to infection, further studies
are needed to determine whether BST-2 inhibits release of PR8
and/or activates proinﬂammatory gene expression during infec-
tion of ATII cells.
An additional antiviral effector protein that is induced by IFN,
IFITM3, was detected in PR8-infected ATII cells and not in mock-
inoculated cells (Tables 2 and 3). In contrast to BST-2, IFITM3 inhibits
an early step in viral infection, preventing effective viral entry prior to
replication. IFITM3 inhibits membrane fusion of IAV, thereby trapping
viruses in the endocytic pathway, leading to lysosomal degradation of
virions (Desai et al., 2014). There is strong evidence for a role for
IFITM3 in protecting both mice and humans against severe inﬂuenza
disease. Mice lacking IFITM3 have increased viral replication, morbid-
ity, and mortality upon IAV infection (Bailey et al., 2012; Everitt et al.,
2011). A minor human IFITM3 allele that has reduced ability to inhibit
IAV infection in vitro is associated with severe disease upon infection
with seasonal or 2009 pandemic H1N1 viral strains (Everitt et al.,
2011; Zhang et al., 2013). IFITM3 appears to have a protective role
against severe disease upon IAV infection (Bailey et al., 2012; Everitt
et al., 2011). As severe disease corresponds with infection of pulmon-
ary ATII cells, expression of IFITM3 in these cells may be an important
determinant of inﬂuenza disease severity.
Toll-like receptors (TLRs) detect pathogen-associated molecular
patterns, triggering a signaling cascade that leads to expression of
inﬂammatory cytokines and type I IFNs. TLR3 speciﬁcally recognizes
dsRNA produced during viral infections, and type I IFNs up-regulate
expression of TLR3. Our proteomics analyses detected TLR3 in PR8-
infected ATII cells, but not in mock-inoculated cells (Tables 2 and 3).
IAV infection of respiratory epithelial cells triggers TLR3 signaling,
resulting in cytokine expression (Guillot et al., 2005). The TLR3-
mediated response to IAV infection can restrict viral production, but
also contribute to inﬂammatory pathology in the lungs. Because of
this, the outcome of IAV infection in TLR3/ mice is highly
dependent upon the strain and dose of virus. Mice deﬁcient in TLR3
have increased survival than wild-type mice when infected with a
highly pathogenic H5N1 strain or mouse-adapted H3N2 strain
Table 2
Type I interferon-induced proteins increased by PR8 infection of ATII cells.
Uniprot ID Gene Protein name References
Q8R2Q8 BST-2 Bone marrow stromal antigen 2/tetherin Der et al. (1998)
Q9CQW9 IFITM3 Interferon induced transmembrane protein 3 Dolken et al. (2008)
Q99MB1 TLR3 Toll-like receptor 3 Dolken et al., (2008)
Q9R233 Tapasin TAP binding protein Dolken et al. (2008)
P01897 H-2L MHC Class I alpha chain (H2L) Der et al. (1998)
P01898 H-2Q10 MHC Class I alpha chain (Q10) Der et al., 1998
P14426 H-2D(K) MHC Class I alpha chain (D-K) Der et al. (1998)
P01887 B2M β-2 microglobulin Der et al. (1998)
Q07797 Lgals3bp Galectin-3 binding protein Dolken et al. (2008)
P05533 Ly6A Lymphocyte antigen 6 complex, locus A Dolken et al. (2008)
P62631 EF1a2 Eukaryotic translation elongation factor 1 alpha 2 Der et al. (1998)
List of proteins with two or more peptides identiﬁed and signiﬁcantly increased abundance in PR8-infected samples (see Table 3) that were identiﬁed by Interferome v. 2.0 to
be induced by type I IFN.
Table 3
Proteins signiﬁcantly up-regulated in PR8-infected ATII cells.
Uniprot ID Protein name Number of peptides identiﬁed Fold Changea
(P-value)
Host defense
Q8R2Q8 Bone marrow stromal antigen 2 4 25.4 (o0.001)
P05533 Lymphocyte antigen 6A-2/6E-1 4 4.23 (0.018)
Q9R233 TAP binding protein (Tapasin) 4 (0.001)b
Q07797 Galectin-3 binding protein 3 3.51(o0.001)
P01897 MHC Class I alpha chain (H2L) 3 (0.014)b
Q9CQW9 Interferon induced transmembrane protein 3 2 (0.001)b
P01898 MHC Class I alpha chain (Q10) 2 (0.014)b
P14426 MHC Class I alpha chain (D-K) 2 (0.014)b
P01887 β-2 microglobulin 2 (0.001)b
Q99MB1 Toll-like receptor 3 (TLR3) 2 (0.014)b
Cytoskeleton
Q6IFZ6 Cytokeratin 1B 4 2.28 (0.049)
P26040 Ezrin 4 1.40 (0.045)
Q9Z2K1 Cytokeratin 16 2 2.89 (0.013)
P08730/Q61414 Cytokeratin 13 or 15 2 2.23 (0.006)
Protein synthesis
P62631 Eukaryotic translation elongation factor 1 alpha 2 2 1.33 (0.004)
Cellular metabolism
Q05769 Cyclooxygenase-2 3 2.68 (0.006)
Q64467 Glyceraldehyde-3-phosphate dehydrogenase 2 1.53 (0.044)
P-value determined by Student's t-test.
a Fold change expressed as ratio of signal intensity in PR8-infected/mock
b G-test when not detected in mock.
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(Le Gofﬁc et al., 2006; Leung et al., 2014). In contrast, TLR3/ mice
have no survival advantage when infected with a 2009 pandemic
H1N1 virus (Leung et al., 2014). A common polymorphism in the
TLR3 gene has been associated with severe disease upon infection
with 2009 pandemic H1N1 virus (Esposito et al., 2012). Thus, TLR3
may contribute to either pathogenesis or viral suppression during
IAV infection of the alveoli.
Type I IFNs also activate the MHC class I antigen processing and
presentation pathway, which is critical for recognition of virus-
infected cells by cytotoxic T cells. IFN-β produced by RSV-infected
epithelial cells stimulates expression of various components of the
MHC class I processing and presentation pathway (Jamaluddin
et al., 2001). Several components of MHC I proteins such as
β-2-microglobulin and various alpha chains were up-regulated
by PR8 infection of ATII cells (Tables 2 and 3). Under the inﬂuence
of type I IFNs, enhanced MHC I antigen processing and presenta-
tion by the ATII cells may render these cells to be targeted by
cytotoxic CD8þ T cells during PR8 infection in the lungs.
Proteins that are associated with the cellular cytoskeleton and
intracellular trafﬁcking had increased abundance in PR8-infected
Table 4
Proteins signiﬁcantly down-regulated in PR8-infected ATII cells.
Uniprot ID Protein name Number of peptides identiﬁed Fold changea
(P-value)
Cell death and stress response
Q60930 Voltage-dependent anion channel 2 21 0.80 (0.042)
Q60932 Voltage-dependent anion channel 1 6 0.71 (0.002)
Q01853 Transitional endoplasmic reticulum ATPase 5 0.51 (0.044)
Q69ZN7 Myoferlin 5 0.63 (0.008)
Q6P069 Sorcin 2 (0.014)b
Q8R1V4 ER stress response protein 25 2 0.64 (0.049)
Proteolysis
P49722 Proteasome, subunit, alpha type 2 17 0.76 (0.032)
O55234 Proteasome, subunit, beta type 5 13 0.66 (0.017)
P57716 Nicastrin 3 0.57 (0.002)
P17047 Lysosomal-associated membrane protein 2 2 0.25 (0.014)
Chromatin formation and DNA damage response
P62806 Histone H4 55 0.68 (0.026)
Q9D2U9 Histone H2ba, H2bb 34 0.87 (0.025)
Q9QZQ8 Core histone H2A.1 5 0.62 (0.001)
O54962 Barrier to autointegration factor 1 2 0.72 (0.008)
Mitochondrial
P43024 Cytochrome c oxidase, subunit VI 6 0.5 (0.023)
Q8BW75 Monoamine oxidase B 6 0.64 (0.016)
Q9CZ13 Ubiquinol-cytochrome c reductase core protein 1 5 0.69 (0.005)
Q9CPQ8 ATP synthase, Hþ transporting, mitochondrial F0 complex 4 0.55 (0.02)
Q99JR1 Sideroﬂexin 1 4 0.61 (0.037)
Q99JB2 Stomatin (Epb7.2)-like 2 4 0.72 (0.002)
Q9R112 Sulﬁde quinone reductase-like (yeast) 3 0.52 (0.01)
Q9Z2Z6 Mitochondrial carnitine/acylcarnitine translocase, 20 3 0.52 (0.018)
Q9DCS9 NADH dehydrogenase 1 beta subcomplex, 10 3 0.6 (0.028)
O55126 Protein NipSnap homolog 2 3 0.66 (0.037)
Q8BGH2 Sorting and assembly machinery component 50 3 0.68 (0.017)
Q921G7 Electron transferring ﬂavoprotein, dehydrogenase 2 (0.014)b
Q9DCJ5 NADH dehydrogenase 1 alpha subcomplex, 8 2 0.52 (0.013)
Q8R127 Saccharopine dehydrogenase (putative) 2 0.56 (0.002)
Q9D855 Ubiquinol-cytochrome c reductase binding protein 2 0.71 (0.005)
Q9D0M3 Cytochrome c-1 2 0.73 (0.002)
Cell signaling and adhesion
Q8R2Y2 Melanoma cell adhesion molecule MUC18 6 0.5 (0.006)
Q61490 Activated leukocyte cell adhesion molecule 6 0.64 (0.002)
P11688 Integrin alpha 5 (ﬁbronectin receptor alpha) 4 0.60 (0.002)
Q07113 Insulin-like growth factor 2 receptor 3 (0.014)b
Lipids and polysaccharides metabolism
Q8C166 Copine I 11 0.67 (0.029)
P50405 Surfactant-associated protein B 8 0.37 (o0.001)
Q64435 UDP glucuronosyltransferase 1-6 6 0.78 (0.05)
Q80UM7 Mannosyl-oligosaccharide glucosidase 2 (0.014)b
Other metabolism
P22437 Prostaglandin-endoperoxide synthase 1 2 0.44 (0.007)
Miscellaneous transmembrane
Q9DBS1 Transmembrane protein 43 11 0.77 (0.037)
Q8VCM8 Nicalin 2 0.47 (0.002)
P-value determined by Student's t-test.
a Fold change expressed as ratio of signal intensity in PR8-infected/mock.
b G-test when not detected in PR8.
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ATII cells (Table 3). These include components of intermediate
ﬁlaments (cytokeratins) and the actin network (ezrin). Other
proteomics studies have reported an increased abundance of
cytokeratins in various mammalian cell types infected by inﬂuenza
A viruses (Liu et al., 2008; Vester et al., 2009). Arcangeletti et al.
(1997) demonstrated co-localization of inﬂuenza NP with cytoker-
atin and a disruption of intermediate ﬁlaments late in the viral
replication cycle. Furthermore, treatment of cells with an inhibitor
of intermediate ﬁlaments resulted in reduced viral production,
which corresponded with reduced cellular and viral protein
synthesis (Arcangeletti et al., 1997). Thus, the cellular cytoskeleton,
speciﬁcally intermediate ﬁlaments, is important for inﬂuenza viral
replication. Potential roles of the cytoskeleton in promoting virus
production include facilitating viral endocytosis, regulating gene
expression, and trafﬁcking of viral components to their correct
location within the cell. Intermediate ﬁlaments are also important
in maintaining polarization of epithelial cells. As inﬂuenza virions
bud from the apical membrane of polarized cells, maintaining the
intermediate ﬁlament network in ATII cells may be important for
directing virus release from the correct side of the cell.
Cellular proteins decreased by PR8 infection
The majority of proteins that were down-regulated by PR8 in
our study were associated with either the inner or outer mito-
chondrial membranes (Table 4). Proteomics analysis identiﬁed
reduced levels of polypeptides that are components of the three
main enzyme complexes in the oxidative electron transport chain:
NADH dehydrogenase complex I, cytochrome b–c1 complex, and
the cytochrome oxidase complex, in PR8-infected samples. Several
other mitochondrial proteins that regulate apoptosis were also
detected in lower abundance in PR8-infected samples. The PB1-F2
protein of PR8 enhances mitochondrial permeability through
interactions with cellular proteins in the inner and outer mito-
chondrial membranes (Zamarin et al., 2005). Proteins belonging to
these two mitochondrial compartments were down-regulated in
our study (Table 4). Reduced expression of these proteins may
alter the permeability and membrane potential of mitochondria,
thereby interfering with energy transduction and promoting
cellular apoptosis. IAV has mechanisms to delay apoptosis of the
host cell, which may be necessary to allow for sufﬁcient time for
viral replication (Zhirnov et al., 2002). IAV also beneﬁts from
cellular apoptosis. Caspase 3 activity enhances production of IAV
by promoting the transport of viral ribonucleoprotein complexes
out of the nucleus (Wurzer et al., 2003). In addition to decreased
levels of proteins that regulate cell death at mitochondrial mem-
branes, PR8-infected cells had reduced levels of other proteins
involved in response to DNA damage, other cell stress, or protein
degradation (Table 4).
Proteins involved in chromatin formation were down-regulated
by PR8 infection including core histone proteins H2A.1, H2B, and
H4 (Table 4). Inﬂuenza viruses undergo transcription and replica-
tion in close association with cellular chromatin and have mechan-
isms that alter chromatin structure. The NP and M1 proteins of IAV
bind to core histone proteins (Garcia-Robles et al., 2005; Zhirnov
and Klenk, 1997). NP binding may be involved in anchoring the
viral RNA to cellular chromatin and M1 may be important for
release of the viral ribonucleoprotein complex from the nucleus.
Modiﬁcation of cellular gene expression through chromatin remo-
deling may have important roles during viral infection. As inﬂu-
enza virus steals caps from cellular mRNAs, enhancement of
cellular transcription concurrent with viral transcription would
support viral gene expression. In contrast, inhibition of cellular
gene expression would beneﬁt the virus by inhibiting the cellular
antiviral response. For example, the NS1 protein of an H3N2 strain
of IAV suppresses cellular transcription of antiviral genes through
a histone-like sequence (Marazzi et al., 2012). Other proteomics
analyses have identiﬁed histone proteins as being down-regulated
(Coombs et al., 2010; Liu et al., 2012) or up-regulated (Coombs
et al., 2010; Kroeker et al., 2012) by IAV infection. The differences
in these ﬁndings may be due to different viral strains, host cell
species and types, the speciﬁc histone proteins and subcellular
fractions analyzed by the study, and the timing within the viral
replication cycle.
Validation of proteomics data
To validate the mass spectrometry based quantiﬁcation, four
proteins with increased abundance in PR8-infected ATII cells (BST-
2, ezrin, TLR3, and IFITM3) and one with decreased abundance
(histone H2B) were selected for immunoblot and densitometry
analysis (Fig. 3). The proteomics data showed that BST-2 and ezrin
had signiﬁcantly increased levels in PR8-infected compared to
mock-inoculated ATII cells (Table 3). In agreement with the
proteomics analysis, the immunoblot shows that expression of
BST-2 was enhanced in PR8-infected cells, showing multiple
glycosylated forms of BST-2 (Fig. 3A), which have been stipulated
to correlate with the antiviral activity of BST-2 (Mangeat et al.,
2012). Ezrin also had a stronger signal in PR8-infected compared
to mock-inoculated cells by immunoblot analysis (Fig. 3A). TLR3
and IFITM3 were only detected in PR8-infected samples by mass
spectrometry (Table 3), whereas both proteins were detected in
mock samples at lower abundance than PR8-infected ATII cells by
immunoblot analysis (Fig. 3A). Multiple histone proteins had
decreased abundance in PR8-infected, compared to mock-inocu-
lated, ATII cells as determined by LC–MS (Table 4). Histone 2B was
analyzed further by immunoblot analysis, which conﬁrmed
reduced levels in PR8-infected cells (Fig. 3B).
ATII-speciﬁc proteins identiﬁed by LC–MS
We previously showed that murine ATII cells cultured on
collagen/matrigel in the presence of keratinocyte growth factor
maintain expression of an ATII phenotype-speciﬁc protein, LBP180
(ABCA3) (Kebaabetswe et al., 2013). Through proteomics analyses,
we identiﬁed ATII cell-speciﬁc proteins in both PR8-infected and
mock-inoculated samples, further conﬁrming that these cultures
maintained an ATII phenotype in vitro. Single peptides that
mapped to ATII-speciﬁc proteins LBP180 and lipocalin were
detected in our samples (Supplemental dataset). As shown in
Table 5, we also identiﬁed multiple ATII-speciﬁc proteins by the
detection of two or more peptides, including the four pulmonary
surfactant proteins (SP)-A, B, C and D. These proteins have been
identiﬁed by numerous studies to be speciﬁcally expressed by ATII,
and not ATI cells in the alveoli (Gonzalez et al., 2005; Kalina et al.,
1992; Mulugeta et al., 2002; Voorhout et al., 1992; Walker et al.,
1986; Weaver et al., 1988). PR8 infection inhibited expression of
SP-B, but did not alter the expression of SP-A, C, D, or other ATII-
speciﬁc proteins (Table 5).
ATII cells are capable of trans-differentiation into cells with an ATI
phenotype in the alveoli and during in vitro culture (Adamson and
Bowden, 1974; Dobbs et al., 1988). Therefore, we also searched the
proteomics data for proteins that are speciﬁc to ATI cells. Two proteins
commonly used to distinguish ATI from ATII cells, T1α and aquaporin
5, were not detected in our samples (Nielsen et al., 1997; Williams
et al., 1996). However, other proteins that have been identiﬁed in ATI,
but not ATII, cells by immunohistochemistry in rat or human lung
tissue: tissue inhibitor of metalloproteinase (TIMP3) and agrin (Dahlin
et al., 2004; Gonzalez et al., 2005), were detected in our ATII cell
cultures (Supplemental table). Three additional ATI markers, SPARC,
caveolin-1, and carboxypeptidase M, were identiﬁed by single peptides
in our analysis (Supplemental Dataset). Thus, our ATII cultures express
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Fig. 3. Validation of proteomics data by immunoblotting. At 24 h post-infection of murine ATII cells with PR8 or mock treatment, equal volumes of whole cell lysates were
analyzed by immunoblot analysis of proteins that had (A) increased or (B) decreased abundance as determined by proteomics analysis. Densitometry was used to quantify
band intensities, which are expressed as a ratio of the intensity of the speciﬁc protein band to the corresponding band for β-actin, after background correction. The data are
representative of three replicate experiments. BST-2¼bone marrow stromal antigen 2, H2B¼histone 2B, IFITM3¼ interferon-induced transmembrane protein 3, TLR3¼toll-
like receptor 3.
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some proteins that are speciﬁcally expressed by ATI cells. This is not
surprising because the ATII cells were cultured for six days prior to
proteomics analysis. Although culture on matrigel/collagen with
keratinocyte growth factor supports maintenance of the ATII cell
phenotype, some cells may undergo trans-differentiation to an ATI
cell phenotype (Kebaabetswe et al., 2013). None of the ATI-speciﬁc
proteins that were identiﬁed had signiﬁcantly altered levels in PR8-
infected samples (Supplemental table).
Analysis of SP-B expression by PR8-infected ATII cells
SP-B is required for the production of functional pulmonary
surfactant, which is essential for preventing alveolar collapse
(Hawgood, 2004). Our proteomic analysis indicated signiﬁcantly
reduced expression of SP-B in PR8-infected ATII cells (Fold change
0.37; P-value o0.001) (Table 5). Due to the critical role of SP-B in
the biosynthesis of pulmonary surfactant, we further validated the
LC–MS data by immunoﬂuorescence and immunoblot analysis of
PR8-infected ATII cells in vitro. Mock-inoculated cells had distinct,
punctate immunoﬂuorescence, indicating the SP-B in cytoplasmic
lamellar bodies (Fig. 4A, C and D). In contrast, there were very few
cells with SP-B-speciﬁc ﬂuorescence in PR8-infected cultures
(Fig. 4B). Immunoblotting demonstrated the absence of the 43
kDa pro-SP-B band in PR8-infected ATII cell lysates (Fig. 4E),
indicating that the sparse antigen detected by immunoﬂuores-
cence assay was below the limit of detection of the immunoblot. In
agreement with the immunoﬂuorescence assay, peptides that
mapped to SP-B were also detected in PR8-infected samples by
LC-MS (Table 5). Thus, both immunoﬂuorescence and immuno-
blotting assays conﬁrmed the reduced expression of SP-B in PR8-
infected ATII cultures demonstrated by proteomic analysis.
The mature form of SP-B is a small hydrophobic peptide that
organizes the phospholipids of surfactant, resulting in a structure
that effectively reduces the surface tension at the air-liquid inter-
face of the alveoli. Targeted disruption of the SP-B gene in mice
and hereditary SP-B deﬁciency in humans are associated with
alterations in surfactant production and lethal respiratory failure
at birth (Clark et al., 1995; deMello et al., 1994; Nogee et al., 1994).
In contrast, deletion of each of the other three surfactant protein
genes in mice alters surfactant homeostasis, but does not result in
neonatal death (Botas et al., 1998; Glasser et al., 2001; Korfhagen
et al., 1996). Furthermore, studies have shown that polymorphisms
in SP-B are associated with severe disease upon infection by
inﬂuenza A virus (To et al., 2014), respiratory syncytial virus
(Puthothu et al., 2007), or non-infectious causes of acute respira-
tory distress (Currier et al., 2008; Gong et al., 2004). Down-
regulation of SP-B during a pulmonary inﬂuenza virus infection
may disrupt surfactant homeostasis and contribute to respiratory
distress.
The decreased SP-B levels in PR8-infected samples may be a direct
result of viral infection or an indirect effect of proinﬂammatory
cytokines produced by the infected cells. Expression of SP-B is
regulated by various growth factors, hormones, and inﬂammatory
mediators, including ceramide, nitric oxide, and cytokines (Salinas et
al., 2003; Sparkman et al., 2006; Whitsett et al., 1992a; Wispe et al.,
1990). Reduced expression of SP-B has been observed in multiple
systems associated with pulmonary inﬂammation, including infec-
tions and endotoxin-induced acute lung injury (Beers et al., 1999;
Ingenito et al., 2001; Kerr and Paton, 1999). Tumor necrosis factor
(TNF-α) is an inﬂammatory cytokine that decreases expression of SP-
B in cultured respiratory epithelial cells and in murine lungs (Bein et
al., 2013; Pryhuber et al., 1996; Whitsett et al., 1992b; Wispe et al.,
1990). IFN-γ and IL-13 have also been shown to down-regulate
production of the mature SP-B protein by human and rat ATII cells,
respectively (Ito and Mason, 2010). While secreted proteins, including
cytokines, were not evaluated by the current study, we previously
demonstrated that PR8 infection of murine alveolar epithelial
cells induces dramatic upregulation of TNF mRNA expression
(Kebaabetswe et al., 2013). In addition to TNF, expression of other
proinﬂammatory cytokines is induced by PR8 infection of murine
alveolar epithelial cells (Kebaabetswe et al., 2013). The potential role
of these cytokines in down-regulation of SP-B production during PR8
infection is the focus of ongoing studies.
Materials and methods
Virus preparation
Human inﬂuenza A/PR/8/34/H1N1 virus (PR8) was obtained
from BEI Resources. Madin–Darby canine kidney (MDCK) cells
were purchased from American Type Culture Collection. PR8 was
propagated and titrated by plaque assay in MDCK cells in media
containing 0.1% BSA and TPCK-trypsin (Sigma-Aldrich, St. Louis,
MO; 1 ug/ml).
Alveolar type II cell culture and virus infections
Animal protocols were approved by the University of Idaho
Animal Care and Use Committee according to the National Research
Council Guide for the Care and Use of Laboratory Animals. ATII cells
were isolated from 6 to 8 week old C57BL/6 mice as previously
described (Kebaabetswe et al., 2013). To maintain an ATII cell
phenotype, ATII cells from 6 mice were pooled and cultured on
millicell inserts (EMD Millipore, Billerica, MA) coated with 70% rat
Table 5
ATII phenotypic proteins identiﬁed by proteomics analysis.
Uniprot ID Protein name Number of peptides Positive samplesa Fold changeb (P-value) References
Mock PR8
Q02496 Mucin-1 3 4 4 1.009 (0.974) Gonzalez et al. (2005)
Q8VCM7 Fibrinogen gamma chain 5 4 4 0.955 (0.865) Gonzalez et al. (2005)
P35242 Surfactant protein A 3 4 4 0.891 (0.614) Walker et al. (1986)
P50405 Surfactant protein B 8 4 4 0.37 (o0.001)c Weaver et al. (1988)
P21841 Surfactant protein C 2 4 4 0.905 (0.771) Kalina et al. (1992)
P50404 Surfactant protein D 5 4 3 0.893 (0.774) Voorhout et al. (1992)
P14094 Na/K-transporting ATPase, beta-1 10 4 4 0.865 (0.328) Gonzalez et al. (2005)
Q91VS7 Microsomal glutathione S-transferase 1 10 4 4 0.494 (0.068) Gonzalez et al. (2005)
P-value determined by Student's t-test.
a Number of replicate samples (of four for each treatment) in which peptides were detected.
b Fold change expressed as ratio of PR8-infected/mock.
c Signiﬁcantly regulated by PR8 infection.
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tail collagen and 30% BD Matrigel (BD Biosciences, San Jose, CA), in
DMEM/10% FBS supplemented with keratinocyte growth factor
(KGF; 10 ng/ml; ProSpec, Rehovot, Israel) for 5 days. Quadruplicate
cultures of cells were inoculated with PR8 (MOI 0.1-1) in the
presence of TPCK-trypsin or mock treated with media for 24 h.
Mass spectrometry sample preparation, data acquisition, and analysis
Four samples each of mock-inoculated and PR8-infected ATII cells
were isolated from collagen/matrigel by dissolving the matrix in
collagenase and dispase. The cells were washed in 150mM ammo-
nium bicarbonate buffer followed by lysis in 8 M urea, which also
served to inactivate PR8. The samples were then sent to the Paciﬁc
Northwest National Laboratory (Richland, WA) on dry ice for proteo-
mics analyses in duplicate using LC–MS and the AMT tag approach
(Zimmer et al., 2006) (see Supplemental methods for full experi-
mental details). The peak area values (i.e., abundances) for the ﬁnal
peptide identiﬁcations were processed in a series of steps using
MatLabs R20111 that included quality control, normalization, protein
quantiﬁcation, and comparative statistical analyses. Peptides were
normalized using a statistical procedure for the analysis of proteomic
normalization strategies (SPANS) that identiﬁes the peptide selection
method and data scaling factor that introduces the least amount of
bias into the dataset (Webb-Robertson et al., 2011). The peptide
abundance values were normalized across the technical replicates
with a rank invariant peptide subset using a mean centering of the
data. Normalized log10 abundance values were averaged across all
technical and biological replicates (n¼8). Peptides were evaluated
with a 2-sample t-test and a G-test to identify quantitative and
qualitative signiﬁcance patterns, respectively, in the peptide data
(Webb-Robertson et al., 2010). Peptide level signiﬁcance patterns
were used for protein roll-up to select appropriate peptides for
protein quantiﬁcation. Proteins were quantiﬁed using a standard R-
Rollup method (Matzke et al., 2013; Polpitiya et al., 2008) using the
most abundant reference peptide, after ﬁltering the peptides that
were redundant, had low data content, or were outside the dominant
signiﬁcance pattern. Protein roll-up identiﬁed 1156 mouse proteins
and 6 viral proteins. Comparative statistical analyses of control and
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Fig. 4. PR8 infection inhibits expression of SP-B in ATII cells. ATII cells were mock-treated or infected with PR8. At 24 h post-infection, cells were analyzed for SP-B
expression. (A–D) Immunoﬂuorescence assay with SP-B labeled red and nuclei stained with DAPI (blue). Panels A and B show epiﬂuorescence microscopy of 40 ﬁelds in
(A) mock and (B) PR8-infected ATII cells. The dashed rectangle in (A) is magniﬁed in panel C to show the punctate pattern of ﬂuorescence in SP-B expressing cells.
(D) Imaging of SP-B signal in mock-inoculated ATII cells by confocal microscopy. Scale bar indicates 5 μm. The projected Z-stack and its corresponding orthogonal views are
indicated by the cross lines. (E) Immunoblot analysis, with band sizes in kDa shown on the left. Densitometry was used to quantify band intensities, which are expressed as a
ratio of the intensity of the SP-B band to the corresponding band for β-actin, after background correction. The data are representative of two replicate experiments.
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infected samples were performed using a 2-sample t-test to assess
differences in protein average abundance, and a G-test to assess
associations among factors due to the presence/absence of response.
Identiﬁcation of IFN-regulated proteins was performed using the
Interferome v.2.0 database (http://interferome.its.monash.edu.au/
interferome/) (Rusinova et al., 2013).
Immunoblotting and densitometry analysis
Mock and PR8 infected ATII cells were lysed in NP40 lysis buffer
(1% NP40, 0.1% SDS, 0.5% sodium-deoxycholate, protease inhibi-
tors). Equal volumes of samples were electrophoresed on 4–20%
SDS page gels (Thermo Scientiﬁc, Rockford, IL) and transferred to
polyvinylidene diﬂuoride (Thermo Scientiﬁc) or nitrocellulose
(Schleicher and Schuell, Keene, NH) membranes. After blocking
with either 5% BSA or milk, membranes were incubated with
antibodies against BST-2 (Santa Cruz Biotechnology, Dallas, TX),
ezrin (Abcam, Cambridge, MA), histone H2B (Abcam), SP-B (Santa
Cruz Biotechnology), IFITM3 (Santa Cruz Biotechnology), or TLR3
(eBioscience, San Diego, CA). With the exception of TLR3, all blots
were incubated with either anti-rabbit (Thermo Scientiﬁc) or anti-
goat (Southern Biotech, Birmingham, AL) horseradish peroxidase
(HRP)-conjugated secondary antibodies. Anti-TLR3 was detected
with biotinylated anti-rat IgG (eBioscience) followed by avidin-
HRP (eBioscience). A β-actin antibody conjugated to HRP was used
as a loading control (Abcam). HRP was detected on ﬁlm with
Supersignal West Pico chemiluminescence substrate (Thermo
Scientiﬁc). Protein bands were quantiﬁed by densitometric scan-
ning of exposed ﬁlm and analysis with ImageJ (National Institutes
of Health, Bethesda, Maryland). For each protein, the speciﬁc
densitometry was determined by subtracting the background
signal using areas adjacent (above and below) to the speciﬁc
protein band and dividing by the corresponding background-
corrected β-actin value.
Indirect immunoﬂuorescence assay
After 24 h, PR8 and mock-infected cells were ﬁxed with 4%
formaldehyde and permeabilized with 0.2% Triton X-100. Viral
antigen was detected with goat antiserum NR-3148, which recog-
nizes the hemagglutinin protein of PR8 (BEI Resources). SP-B was
detected using a goat polyclonal SP-B antibody (Santa Cruz
Biotechnology). Anti-goat-555 secondary antibody (Invitrogen,
Carlsbad, CA) was used to detect both the PR8 infection and
SP-B. Cells were stained with 40,6-diamidino-2-phenylindole
(DAPI) to visualize the nuclei and were photographed on a Nikon
Eclipse Fluorescence Microscope with Hamatsu digital camera and
Metamorph software (Molecular Devices, Sunnyvale, CA). Confocal
imaging was performed on an Olympus Fluoview 1000 upright
microscope with a 60 Plan Apo oil objective lens and FluoView
ASW software. Stacked images were captured using step sizes
ranging from 0.32 μm to 0.42 μm. Z-stack analysis was performed
in Imaris version 7.2.1 (Bitplane, Zurich, Switzerland).
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